Company

WHO WE ARE

Since its creation, Orion Lab has been guided by a clear and unwavering mission: to guarantee reliable access to essential cancer treatments for patients in Algeria and beyond. In a country where access to oncology medicines has long been dependent on imports, we have built a fully integrated pharmaceutical platform that combines high-containment technology, rigorous international quality standards, and a long-term vision for national health sovereignty.

Orion Lab is more than a manufacturer. It is a strategic partner to healthcare systems, hospitals, and pharmaceutical companies. Our commitment is to provide high-quality oncology medicines at sustainable costs while supporting the development of a strong, autonomous pharmaceutical ecosystem. We have invested heavily in modern infrastructure and human capital to ensure that our manufacturing facilities operate at the same level as leading international sites.

Today, Orion Lab is a key industrial player in Algeria’s pharmaceutical landscape and is rapidly expanding its international footprint through CMO/CDMO partnerships and exports. We are proud to contribute to making innovative cancer therapies more accessible and affordable to patients who need them most.

Allel and Seddik AMRY - Founders

OrionLab is an Algerian pharmaceutical company founded in 2018 in Oran by three brothers sharing a single vision : to reduce dependency on imports and guarantee patient access to innovative therapies. Our team leverages over 25 years of industry experience and collaborates with leading European equipment suppliers to meet the highest global manufacturing standards.

Establishment of OrionLab

Commissioning of the OSD production line

Commissioning of the injectable line and start of fill-and-finish operations for the first biosimilar

2017
2020
2023
2024
2025
2026

Completion of structural works

Market launch of OrionLab’s first product

Launch of EMA certification process and introduction of CMO & CDMO services

“ Today, Orion Lab stands as a reference point in Algeria’s pharmaceutical industry, bridging national health priorities and international collaboration “

Création du laboratoire

2017

Mise en exploitation ligne OSD petits volumes

Juillet 2019

Mise en exploitation ligne injectable

Septembre 2020

CMO (contract manufacturing) et exportation

Janvier 2021

Achèvement des gros oeuvres de l’usine

Août 2018

Mise en exploitation ligne OSD grands volumes

Septembre 2019

Certification EMA, ANVISA, FDA pour l’OSD

Septembre 2020

Certification EMA, ANVISA, FDA pour l’injectable stérile

Septembre 2021

OUR VISION

We are driven by a mission to make oncology treatments accessible to all patients while positioning Algeria as a strategic manufacturing hub for North Africa and beyond.

Our model is built on quality, innovation, and strong public-private partnerships.

  • Strengthening health sovereignty
  • Reducing import dependency
  • Exporting to MENA, Africa & Europe
  • Becoming a CMO/CDMO partner of choice
  • Leading in biosimilars manufacturing

“ Our ambition is to create lasting impact, both for patients and for our partners “

MANUFACTURING SITE

Located in the Hassi Ameur industrial zone (Oran), our 5,000 m² GMP-compliant facility spans six operational levels. The site integrates all steps of the pharmaceutical manufacturing chain, from raw materials to final packaging, ensuring safety, efficiency, and quality.

  • OSD production unit
  • Sterile injectable unit
  • Microbiology and physicochemical QC labs
  • Automated environmental monitoring

“ This strategic location offers excellent export connectivity to Europe, Africa, and the Middle East, making Orion Lab an ideal regional manufacturing hub “

STRATEGIC POSITIONING & PARTNERSHIPS

Thanks to its strategic location, regulatory alignment, and high-containment expertise, Orion Lab positions itself as a trusted CMO/CDMO partner for regional and international markets.

  • Cost-competitive manufacturing in Algeria
  • Access to MENA, Africa, and EU markets
  • Full regulatory and technical support
  • Biosimilar & high-potency expertise
  • Long-term partnership model

“ Our collaborations are built on trust, quality, and shared vision for patient access and healthcare independence “

Services

ORAL SOLID DOSAGE UNIT

Our OSD line is designed to deliver high-performance and flexible production, covering a wide range of high-potency oncology medicines. Operations are performed under strict containment conditions to ensure both product quality and operator safety.

  • 1,200 m² facility
  • Wet/dry granulation : from 3 to 10 litres
    from 15 to 160 litres
  • Annual capacity : 100 millions tablets/year/shift
    40 millions capsules/year/shift
  • Advanced formulation: spray drying, HME (Hot Melt Extrusion), solubility enhancement, roller compactor
  • Containment systems with isolators & CIP (Clean In Place)
  • Handling of high-potency products & OEL ≤ 0.01 µg/m³ compliance

“ This production unit combines technological excellence and industrial agility, meeting the needs of both local and international partners “

The sterile injectable unit allows us to manufacture high-quality, aseptically filled products, including biosimilars, making OrionLab a pioneer in Algeria. Our facility is equipped to handle both small and large batches under strict GMP conditions.

  • 900 m² cleanroom
  • Batch size from 20 to 2000 litres
  • Aseptic fill-finish, lyophilization, isolators : 2 millions vials/year/shift
  • Dedicated line for prefilled syringes, cartridges, and vials : 5 millions units/years
  • Single-use formulation systems
  • Full serialization & biosimilars

“ By combining advanced technologies and flexible capacity, we offer a complete injectable manufacturing solution for clinical and commercial supply “

STERILE INJECTABLE UNIT

IMG3203

QUALITY CONTROL LABORATORY

Our QC laboratory is fully equipped to support every stage of production with robust analytical capabilities. Operating under GMP standards, it ensures the quality, safety, and consistency of all products.

  • Physico-chemical testing (dissolution, friability, LOD, etc.)
  • Microbiology and sterility testing
  • Stability studies per ICH guidelines
  • Method validation and external testing services
  • LNCPP-accredited
  • HPLC equipped with various detectors
  • GC equipped with various detectors and headspaces
  • Automated dissolution baths
  • UV-Visible spectrometer
  • Polarimeter, X-Ray Diffraction, Thermogravimetric Analyzer (TGA), Differential scanning calorimetry (DSC), Osmometer

“ This infrastructure supports both in-house production and analytical services for partners “

OUR VISION

La zone de production OSD s’étend sur une surface de 1200 m2 est constituée de deux ligne de granulation :

  • Petits volumes : pour la réalisation de lots de 3 à 10 litres.
  • Grands volumes : pour la réalisation de lots de 15 à 160 litres.

Les bonnes pratiques de production actuelles exigent de plus en plus un confinement total au cours du procédé, pour la protection à la fois des opérateurs et de l’environnement. Les systèmes de procédé intégré offrent non seulement un confinement, mais ils assurent également une productivité accrue via une automatisation, un rendement supérieur et des procédures de nettoyage efficaces. Ainsi, tout le processus de fabrication est réalisé sous haut confinement via l’utilisation d’un isolateur, d’une ligne de granulation complète avec BIN et valves spécifiques, des extracteurs de poudre confinés…et le nettoyage est automatique grâce au CIP (cleaning in place).

Les stoppers, caps et autres ustensiles nécessaires au remplissage sont stérilisés à la vapeur dans un autoclave à double portes. L’autoclave est également utilisé pour stériliser les produits nécessitant une stérilisation post remplissage. Enfin, les flacons sont inspectés visuellement à 100% . Les flacons sans défaut sont étiquetés, emballés et envoyés au magasin de produits finis.

LABORATOIRE DE CONTRÔLE QUALITÉ

Le laboratoire de contrôle qualité s’étend sur une superficie de 570m2 dont 178 m2 dédiés pour le laboratoire microbiologique. Une équipe pluridisciplinaire formée d’ingénieurs, Pharmacien & Techniciens sont recrutés pour assurer le contrôle analytique des matières-premières, produits semi-finis et produits finis.

Le laboratoire dispose d’outils de contrôle adaptés permettant de valider les étapes de faisabilité et d’optimiser les paramètres de production mais aussi pour le contrôle des produits en cours de production (tests de dissolution, désagrégation, uniformité de masse, dureté, friabilité, mesure LOD;…). Les études de stabilité sont réalisées, en interne, selon les normes ICH. Le laboratoire, accrédité par le LNCPP, assurera les contrôles en interne ainsi que des prestations de services pour des partenaires pour les analyses suivantes :

Contrôles physico-chimiques

Contrôles microbiologiques

Études de stabilité

All our facilities will be certified by the FDA, EMA, and ANVISA.

Events

DISCOVER OUR EVENTS

novembre 24, 2025

FIA 2025

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus hendrerit. Pellentesque aliquet nibh nec urna. In nisi neque, aliquet vel, dapibus id,…

novembre 24, 2025

Hospitalia 2025

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus hendrerit. Pellentesque aliquet nibh nec urna. In nisi neque, aliquet vel, dapibus id,…

novembre 24, 2025

IATF 2025

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus hendrerit. Pellentesque aliquet nibh nec urna. In nisi neque, aliquet vel, dapibus id,…

novembre 24, 2025

Signature avec Saidal

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus hendrerit. Pellentesque aliquet nibh nec urna. In nisi neque, aliquet vel, dapibus id,Lorem…

Contact & Information

CONTACT US

Section n°04, lot n°60A, 61A Ex 102 Zone industrielle Hassi Ameur - 31130
Hassi Bounif, Oran, Algeria.

For partnership inquiries (CMO/CDMO, tech transfer, export collaborations), please contact our Business Development team.